ConductScience.org, home

Comparison · NCT02067039-1b5fd69e

HIV Self-testing vs Information Only: Frequency of HIV Testing by Internet-recruited MSM.

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

2 sourcestrial-comparisons-2026-03-23-0.1.0

Download JSON
Cite this record

ConductScience Library. HIV Self-testing vs Information Only: Frequency of HIV Testing by Internet-recruited MSM. Trial comparisons, record NCT02067039-1b5fd69e. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT02067039-1b5fd69e

On this page

Measures6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNote
Risk in group 10.7660.7390.791wilson
Risk in group 20.220.1950.247wilson
Risk difference, group 1 minus group 20.5460.5080.581newcombe hybrid score
Risk ratio, group 1 over group 23.483.083.94log
Odds ratio, group 1 over group 211.69.4214.3log
Number needed to treat, for one more participant with the outcome on HIV Self-testing than on Information Only1.831.721.97from the risk difference interval

Groups2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov code
Group 1HIV Self-testing
The intervention group of MSM (HIV negative or unaware of HIV status) will receive 4 rapid HIV test kits - 2 oral fluid tests (OraQuick), and 2 finger-stick blood tests (Sure Check). Men in the randomized controlled trial will complete short follow-up surveys at 3-month intervals during the 12-month follow-up period, and men in the intervention arm will be allowed to order additional test kits to replenish the ones they use or give away. At month 12, all HIV-negative or those who are unaware of their HIV status participants will be sent 1 oral fluid test (OraQuick), 1 finger-stick blood test (Sure Check), and a dried blood spot (DBS) specimen collection kit to be mailed to Emory University after collecting a blood sample for laboratory testing.~OraQuick in home \& Sure Check HIV tests: Provision of OraQuick in home \& Sure Check HIV tests
7771,014OG000
Group 2Information Only
All comparison group of MSM (HIV negative or unaware of HIV status) will take a baseline survey. Men in the randomized controlled trial will complete short follow-up surveys at 3-month intervals during the 12-month follow-up period. At month 12, all HIV-negative and unaware of their HIV status comparison arm participants will be sent 1 oral fluid test (OraQuick), 1 finger-stick blood test (Sure Check), and a DBS specimen collection kit to be mailed to Emory University after collecting a blood sample for laboratory testing.
215977OG001

Outcome

Type
PRIMARY
Title
Frequency of HIV Testing by Internet-recruited MSM.
Description
Frequency of HIV testing \>=3 times reported by participants over a 12-month follow-up period.
Time frame
12 months
Population
percent of MSM who reported testing at least three times over the course of the RCT

Source ClinicalTrials.gov

Trial

Title
Evaluation of Rapid HIV Self-testing Among MSM (eSTAMP)
NCT number
NCT02067039
Phases
NA
Conditions
HIV Infection
Interventions
OraQuick in home & Sure Check HIV tests
Lead sponsor
Centers for Disease Control and Prevention
Results first posted
2020-03-31

Source ClinicalTrials.gov

Source

Release
trial-comparisons-2026-03-23-0.1.0
Release manifest SHA-256
f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
AACT copy
2026-03-23
Tables read
outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet

Source ClinicalTrials.gov

Sources 2

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

For software

Read this comparison from software.

The record is JSON. No key.

GET https://conductscience.org/api/comparisons/v1/NCT02067039-1b5fd69e